RNAscope
Tóm tắt
Từ khóa
Tài liệu tham khảo
Hamburg, 2010, The path to personalized medicine [Erratum appeared in N Engl J Med 2010;363:1092], N Engl J Med, 363, 301, 10.1056/NEJMp1006304
Sotiriou, 2007, Taking gene-expression profiling to the clinic: when will molecular signatures become relevant to patient care?, Nat Rev Cancer, 7, 545, 10.1038/nrc2173
van 't Veer, 2002, Gene expression profiling predicts clinical outcome of breast cancer, Nature, 415, 530, 10.1038/415530a
Bonner, 1997, Laser capture microdissection: molecular analysis of tissue, Science, 278, 10.1126/science.278.5342.1481
Levsky, 2003, Fluorescence in situ hybridization: past, present and future, J Cell Sci, 116, 2833, 10.1242/jcs.00633
Matos LL, 2010, Immunohistochemistry as an important tool in biomarkers detection and clinical practice, Biomark Insights, 5, 9, 10.4137/BMI.S2185
Gulley, 2001, Molecular diagnosis of Epstein-Barr virus-related diseases, J Mol Diagn, 3, 1, 10.1016/S1525-1578(10)60642-3
Ambinder, 1994, Detection and characterization of Epstein-Barr virus in clinical specimens, Am J Pathol, 145, 239
Mahmood, 2008, In-situ hybridization of radioactive riboprobes to RNA in tissue sections, Methods Mol Biol, 461, 675, 10.1007/978-1-60327-483-8_45
Player, 2001, Single-copy gene detection using branched DNA (bDNA) in situ hybridization, J Histochem Cytochem, 49, 603, 10.1177/002215540104900507
Bushnell, 1999, ProbeDesigner: for the design of probesets for branched DNA (bDNA) signal amplification assays, Bioinformatics, 15, 348, 10.1093/bioinformatics/15.5.348
Hammond, 2010, American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer, Arch Pathol Lab Med, 134, 907, 10.5858/134.6.907
zur Hausen, 2002, Papillomaviruses and cancer: from basic studies to clinical application, Nat Rev Cancer, 2, 342, 10.1038/nrc798
Canales, 2006, Evaluation of DNA microarray results with quantitative gene expression platforms, Nat Biotechnol, 24, 1115, 10.1038/nbt1236
Segal, 1994, In situ hybridization analysis of lymphoproliferative disorders, Diagn Mol Pathol, 3, 170, 10.1097/00019606-199409000-00006
Beck, 2003, Automated colorimetric in situ hybridization (CISH) detection of immunoglobulin (Ig) light chain mRNA expression in plasma cell (PC) dyscrasias and non-Hodgkin lymphoma, Diagn Mol Pathol, 12, 14, 10.1097/00019606-200303000-00002
Harris, 2007, American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer, J Clin Oncol, 25, 5287, 10.1200/JCO.2007.14.2364
Annecke, 2008, uPA and PAI-1 in breast cancer: review of their clinical utility and current validation in the prospective NNBC-3 trial, Adv Clin Chem, 45, 31, 10.1016/S0065-2423(07)00002-9
Castelló, 2007, Expression of plasminogen activator inhibitors type 1 and type 3 and urokinase plasminogen activator protein and mRNA in breast cancer, Thromb Res, 120, 753, 10.1016/j.thromres.2006.12.016
Nielsen, 2001, Urokinase plasminogen activator is localized in stromal cells in ductal breast cancer, Lab Invest, 81, 1485, 10.1038/labinvest.3780363
Qian, 2003, Recent developments in signal amplification methods for in situ hybridization, Diagn Mol Pathol, 12, 1, 10.1097/00019606-200303000-00001
Raj, 2008, Imaging individual mRNA molecules using multiple singly labeled probes, Nat Methods, 5, 877, 10.1038/nmeth.1253
Femino, 1998, Visualization of single RNA transcripts in situ, Science, 280, 585, 10.1126/science.280.5363.585
Nuovo, 1995, In situ PCR: protocols and applications, PCR Methods Applications, 4, S151, 10.1101/gr.4.4.S151
Speel, 1998, Improved mRNA in situ hybridization on formaldehyde-fixed and paraffin-embedded tissue using signal amplification with different haptenized tyramides, Histochem Cell Biol, 110, 571, 10.1007/s004180050319